Experienced in Acid Sphingomyelinase Deficiency (ASMD)

Guido H. Gerken

Velbert, NW, DE 
Experienced in Acid Sphingomyelinase Deficiency (ASMD)
Velbert, NW, DE 
OverviewLocationsClinical Research

Overview

Guido Gerken practices in Velbert, Germany. Mr. Gerken is rated as an Experienced expert by MediFind in the treatment of Acid Sphingomyelinase Deficiency (ASMD). His top areas of expertise are Liver Failure, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 226 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acid Sphingomyelinase Deficiency (ASMD).

Gender
Male

Locations

Velbert, NW 42549, Germany
Other Locations
Essen, NW 45147, Germany
Duisburg, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase IIb, Double Blind Randomized, Controlled Clinical Trial, to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) - Aramchol 005 Study
A Phase IIb, Double Blind Randomized, Controlled Clinical Trial, to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) - Aramchol 005 Study
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Drug
Study Phase: Phase 2

226 Total Publications

Obeticholic Acid Improves Cholestasis, Liver Fibrosis, and Liver Function in Patients with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid.
Obeticholic Acid Improves Cholestasis, Liver Fibrosis, and Liver Function in Patients with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid.
Journal: Journal of personalized medicine
Published: December 30, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gerken's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 29 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile